Bahji Anees, Cheng Breagh, Gray Samantha, Stuart Heather
Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada (AB, BC, SG, HS); Department of Psychiatry, Queen's University, Kingston, Ontario, Canada (AB).
J Addict Med. 2020 Jul/Aug;14(4):e118-e132. doi: 10.1097/ADM.0000000000000606.
Opioids are among the most commonly used class of illicit drugs. We aimed to produce pooled estimates of mortality risks among people with opioid use disorder (OUD), with a focus upon all-cause mortality, and also overdose-specific causes of death.
Systematic review and meta-analysis of cohorts of people with OUD involving illicit opioids with data on all-cause or overdose-specific mortality.
Of 4247 papers, 92 were eligible, reporting on 101 cohorts that measured all-cause mortality and opioid-overdose mortality. Cohorts (n = 101-229,274) were in North America, Australia, several Eastern and Western European countries, and Asia.
Titles/abstracts and full texts were independently screened by 2 reviewers, with discrepancies resolved via a third reviewer. We extracted data on crude mortality rates (CMRs) per 1000 person-years (PY); we imputed CMRs where possible if not reported by study authors. We also calculated mortality relative risks. Data were pooled using random-effects models; potential reasons for heterogeneity were explored using subgroup analyses and meta-regressions.
The overall all-cause CMR was 18.7 per 1000 PY (95% confidence interval [CI] 17.1-20.3). The overall overdose-specific CMR was 7.0 per 1000 PY (95% CI 6.1-8.0). All-cause and overdose-specific mortality were substantially higher in low/middle-income countries, among those with HIV, and among people who use injection drugs.
Individuals with OUD carry a high risk of all-cause and overdose-specific mortality. Potentially modifiable risk factors, such as HIV and injection drug use, were predictive of mortality risk and are amenable to global efforts aiming to improve access to OUD treatment and targeted harm reduction efforts.
阿片类药物是最常用的非法药物类别之一。我们旨在汇总阿片类药物使用障碍(OUD)患者的死亡风险估计值,重点关注全因死亡率以及特定过量用药导致的死亡原因。
对涉及非法阿片类药物的OUD患者队列进行系统评价和荟萃分析,并获取全因或特定过量用药死亡率数据。
在4247篇论文中,92篇符合要求,报告了101个测量全因死亡率和阿片类药物过量死亡率的队列。队列(n = 101 - 229,274)来自北美、澳大利亚、几个东欧和西欧国家以及亚洲。
两名评审员独立筛选标题/摘要和全文,如有分歧则通过第三名评审员解决。我们提取了每1000人年(PY)的粗死亡率(CMR)数据;如果研究作者未报告,我们会尽可能估算CMR。我们还计算了死亡相对风险。使用随机效应模型汇总数据;通过亚组分析和meta回归探讨异质性的潜在原因。
总体全因CMR为每1000 PY 18.7(95%置信区间[CI] 17.1 - 20.3)。总体特定过量用药CMR为每1000 PY 7.0(95% CI 6.1 - 8.0)。在低收入/中等收入国家、感染艾滋病毒者以及注射吸毒者中,全因死亡率和特定过量用药死亡率显著更高。
OUD患者全因死亡和特定过量用药死亡风险很高。潜在可改变的风险因素,如艾滋病毒感染和注射吸毒,可预测死亡风险,并且适合全球为改善OUD治疗可及性和有针对性的减少伤害工作所做的努力。